Caveats in the interpretation of the surgical literature

British Journal of Surgery

Volumn 95, Issue 5, 2008, Pages 541-546

  Guller, U ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CLINICAL PRACTICE; LAPAROSCOPIC SURGERY; MEDICAL EDUCATION; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; EPIDEMIOLOGY; MEDICAL RESEARCH; STANDARD; STATISTICAL ANALYSIS; SURGERY; WRITING;

BIOMEDICAL RESEARCH; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; SURGERY; WRITING;

EID: 43549106134     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6156     Document Type: Review

References (14)

1. Kurichi JE, Sonnad SS. Statistical methods in the surgical literature. J Am Coll Surg 2006; 202: 476-484.
2. Ioannidis JP. Why most published research findings are false. PLoS Med 2005; 2: e124.
3. Guller U. Surgical outcomes research based on administrative data: inferior or complementary to prospective randomized clinical trials? World J Surg 2006; 30: 255-266.
4. Guller U, DeLong ER. Interpreting statistics in medical literature: a vade mecum for surgeons. J Am Coll Surg 2004; 198: 441-458.
5. Cook DJ, Guyatt GH, Laupacis A, Sackett DL, Goldberg RJ. Clinical recommendations using levels of evidence for antithrombotic agents. Chest 1995; 108(Suppl): 227S-230S.
6. McLeod RS. Issues in surgical randomized controlled trials. World J Surg 1999; 23: 1210-1214.
7. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
8. Guller U, Oertli D. Sample size matters: a guide for surgeons. World J Surg 2005; 29: 601-605.
9. Sterne JA, Davey Smith G. Sifting the evidence - what's wrong with significance tests? BMJ 2001; 322: 226-231.
10. Guller U, Safford S, Pietrobon R, Heberer M, Oertli D, Jain NB. High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233 247 patients. World J Surg 2005; 29: 994-999.
11. Altman DG, Bland JM. Time to event (survival) data. BMJ 1998; 317: 468-469.
12. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002; 359: 1686-1689.
13. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272: 122-124.
14. Freiman JA, Chalmers TC, Smith H JR, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 'negative' trials. N Engl J Med 1978; 299: 690-694.